A global expertise on the prevention of depression and suicide

About 11 people will commit suicide today and every day in Canada.

The Manulife Centre: a centre dedicated to kids and teens

Directed by child psychiatrist Johanne Renaud, the Centre aims to:

  •  improve youth’s access to mental health services
  • evaluate the efficacy of different treatments for depression and prevention methods for depression and suicide in Canadian youth

The research teams are not reproducing what is already in place or adding methods of intervention. They are using scientific process to establish which existing methods are most effective in preventing depression and suicide in youth.

Then they will determine how these interventions, treatments, or therapies can benefit patients in other places in order to reduce the overall rate of depression and suicide in youth.

Learn more about the research projects of the Center: https://douglas.research.mcgill.ca/manulife-centre-breakthroughs-teen-depression-and-suicide-prevention


Depressive and Suicide Disorders Program

The Depressive and Suicide Disorders Program is a superspecialized service for youth and adults who suffer from refractory and/or recurrent major depressive disorder with or without the presence of suicidal behaviour.

The program offers cutting-edge treatment for clients and provides support to families to help them interact with the person in difficulty.

En savoir plus

This program is specifically for:

  •  Youth aged 6 to 18 years who present with mood disorders, such as major depression or dysthymia. These disorders may or may not be associated with anxiety, substance abuse, impulsivity or suicidal behavior or thoughts.
  • Adults suffering from treatment-refractory major depressive disorder.
  • Individuals with a significant personal and/or family history of suicidal behavior.

Services provided

  • Standardized, detailed psychiatric evaluation by a multidisciplinary team
  • Multimodal treatment approach (from 4 to 6 months) including individual, family and group therapy with or without pharmacotherapy (consultations on pharmacological strategies are also offered)
  • Treatment of severe suicidal behavior and/or follow-up of individuals at risk (individual and group therapy)
  • Transcranial magnetic stimulation (TMS)
  • Interventions aimed at suicide prevention, the treatment of chronicity and other complications frequently associated with depression (i.e., school and/or work absenteeism or school drop-outs in children and adolescents), and family support
  • Support for and liaison with referring physicians

Research projects that integrate clinical practice

The team measures the effectiveness of therapeutic interventions at baseline and during treatment and follow-up. They also develop research projects that are integrated into clinical practice.

The McGill Group for Suicide Studies (MGSS), directed by Gustavo Turecki, MD, PhD, is interested in the risk factors associated with suicidal behavior and related conditions, such as depression. The team uses a range of different approaches and methodologies to carry out its research.